Non-Invasive Fat Reduction in the Chin Using Cryolipolysis
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 14
- 试验地点
- 2
- 主要终点
- Proportion of Accurately Identified Pre-Treatment Photos by a Panel of Blinded Independent Reviewers
研究概览
简要总结
The purpose of this study is to further evaluate the safety and efficacy of non-invasive reduction of subcutaneous fat in the submental and submandibular area using Cryolipolysis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 22 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Male or female subjects > 22 years of age and < 65 years of age.
- •Submental and submandibular skin fold thickness > 1cm (measured by caliper).
- •No weight change exceeding 5% of body weight in the preceding month.
- •Agreement to maintain his/her weight (i.e., within 5%) by not making any major changes in diet or exercise routine during the course of the study.
- •Subject has signed a written informed consent form.
排除标准
- •Skin laxity in the neck or chin area for which reduction in submental and submandibular fat may, in the opinion of the investigator, result in an unacceptable aesthetic result.
- •Prominent platysmal bands at rest which may interfere with assessment of submental fat
- •Evidence of any cause of enlargement in the submental area other than localized subcutaneous fat, such as swollen lymph nodes or ptotic submandibular glands.
- •Significant enlargement on the anterior neck that may prevent the proper placement of the applicator e.g. enlarged thyroid glands.
- •Treatment with dermal fillers, radiofrequency or laser procedures, or chemical peels in the neck or chin area (below the mandible) within the past 6 months.
- •Botulinum toxin or other aesthetic drug injections within the neck or chin area (below the mandible) within the past 6 months.
- •History of facial nerve paresis or paralysis (such as Bell's palsy).
- •History of a fat reduction procedure (e.g., liposuction, surgery, lipolytic agents, etc.) or implant in or adjacent to the area of intended treatment.
- •History of prior neck surgery, or prior surgery in the area of intended treatment.
- •Current dental infection.
- •Known history of cryoglobulinemia, cold urticaria, cold agglutinin disease or paroxysmal cold hemoglobinuria.
- •Known history of Raynaud's disease, or any known condition with a response to cold exposure that limits blood flow to the skin.
- •History of bleeding disorder or is taking any medication that in the investigator's opinion may increase the subject's risk of bruising.
- •Currently taking or has taken diet pills or weight control supplements within the past month.
- •Any dermatological conditions, such as scars in the location of the treatment area that may interfere with the treatment or evaluation.
- •Active implanted device such as a pacemaker, defibrillator, or drug delivery system.
- •Pregnant or intending to become pregnant in the next 6 months.
- •Lactating or has been lactating in the past 6 months.
- •Unable or unwilling to comply with the study requirements.
- •Currently enrolled in a clinical study of an unapproved investigational drug or device.
- •Any other condition or laboratory value that would, in the professional opinion of the investigator, potentially affect the subject's response or the integrity of the data or would pose an unacceptable risk to the subject.
结局指标
主要结局
Proportion of Accurately Identified Pre-Treatment Photos by a Panel of Blinded Independent Reviewers
时间窗: Baseline (pre-treatment) and 12 weeks post treatment
Change in the treated vs. untreated areas will be assessed by observation of changes in surface contour and/or fat volume by an independent photo review of pre-treatment and post-treatment images of the treated areas. Reviewers will be practicing dermatologists or plastic surgeons. All reviewers will be blinded to post-treatment vs. baseline untreated area. The order in which images will be presented will be randomized; for each subject placement of the baseline, pre-treatment image will be randomized for each pair of subject images. Reviewers will be asked to select the baseline photos for each subject photo series and record selections on a data collection form. Success is defined as 70% correct identification of pre-treatment images by at least 70% correct identification of pre-treatment images by two out of three reviewers.
The Number of Unanticipated Adverse Device Effects (UADE) Reported
时间窗: Enrollment through the 12 week final follow-up visit
The primary safety endpoint is the count of unanticipated adverse device effects (UADEs) reported in the study period. It is expected there will be zero UADEs.
次要结局
- Subject Satisfaction(12 weeks post-treatment)
- Change in Fat Layer Thickness of the Submental Area as Measured by Caliper(Baseline and 12 week post-treatment)